Search Results - Boards

Ticker	Board	Posts	Status	Last Post	Category
	ForeverGreen Worldwide Corp. (fka FVRG)	4,095		3 months ago	Delisted
SICPQ	Silvergate Capital Corp	176		5 months ago	Banking and Finance
EGRNF	China Evergrande Group	77		10 months ago	International Markets
EGSE	Evergreen Sustainable Enterprises Inc.	140		2 years ago	Miscellaneous
	Evergreen Gaming Corp (fka EVGEF)	29		2 years ago	Delisted
CVGYY	Convergys Corporation	6		2 years ago	Computers - Hardware
XVGUSD	Verge	52		2 years ago	Coins
EVERGROWUSD	EverGrow Coin	13		2 years ago	Coins
EGCUSD	EverGrow Coin	9		3 years ago	Coins
	SILVERGOLD	131		3 years ago	User's Groups
EVGRF	China Evergrande Nw Egy Vehicle Grp Ltd	3	Closed.	3 years ago	International Markets
	Evergreen-Agra Global Investments Inc (fka EGRN)	1,184		3 years ago	Delisted
CTS	Converge Technology Solutions Corp	40		4 years ago	Internet - Online Services
PTVE	Pactiv Evergreen Inc	5		4 years ago	Food - Processing and Agriculture
EVGUF	Evergold Corp	5		4 years ago	Mining/Resources
	Convergence Ethanol Inc. (fka CETH)	1,662		5 years ago	Delisted
	SPX !GT50SPX DIVERGENCE	5		6 years ago	Market Trends and Strategies
EVRG	Evergy Inc	5		7 years ago	Utilities
	Moving Average Convergence-Divergence (MACD) - cro	5		7 years ago	All Trading - Technical
	Evergreen Energy Inc.(fka EVEIQ)	4,643		8 years ago	Delisted
mems	Convergance Ethanol	28		11 years ago	Oil/Gas/Natural Energy
	Global Convergence Solutions (GCS)	153	Closed.	12 years ago	Telecommunications Networks
	Evergreen Solar Inc. (fka ESLRQ)	1,532		12 years ago	Delisted
	RSI positive divergence and fair SS stocks.	6		12 years ago	Penny Trading - Technical
COMV	Comverge, Inc.	68		12 years ago	Alternative Energy
	EvergreenBancorp Inc (fkaEVGGQ)	38		13 years ago	Banking and Finance
	Positive Divergence Charts	55		13 years ago	User's Groups
	CHINA EVERGREEN ENVIRON (fka CEEC)	15		18 years ago	Delisted
	Wide E-Convergence Technologies Americas Corp (fka	6		18 years ago	Delisted

Ticker

Board

Posts

Status

Last Post

Category

ForeverGreen Worldwide Corp. (fka FVRG)

4,095

3 months ago

Delisted

SICPQ

Silvergate Capital Corp

176

5 months ago

Banking and Finance

EGRNF

China Evergrande Group

10 months ago

International Markets

EGSE

Evergreen Sustainable Enterprises Inc.

140

2 years ago

Miscellaneous

Evergreen Gaming Corp (fka EVGEF)

2 years ago

Delisted

CVGYY

Convergys Corporation

2 years ago

Computers - Hardware

XVGUSD

Verge

2 years ago

Coins

EVERGROWUSD

EverGrow Coin

2 years ago

Coins

EGCUSD

EverGrow Coin

3 years ago

Coins

SILVERGOLD

131

3 years ago

User's Groups

EVGRF

China Evergrande Nw Egy Vehicle Grp Ltd

Closed.

3 years ago

International Markets

Evergreen-Agra Global Investments Inc (fka EGRN)

1,184

3 years ago

Delisted

CTS

Converge Technology Solutions Corp

4 years ago

Internet - Online Services

PTVE

Pactiv Evergreen Inc

4 years ago

Food - Processing and Agriculture

EVGUF

Evergold Corp

4 years ago

Mining/Resources

Convergence Ethanol Inc. (fka CETH)

1,662

5 years ago

Delisted

SPX !GT50SPX DIVERGENCE

6 years ago

Market Trends and Strategies

EVRG

Evergy Inc

7 years ago

Utilities

Moving Average Convergence-Divergence (MACD) - cro

7 years ago

All Trading - Technical

Evergreen Energy Inc.(fka EVEIQ)

4,643

8 years ago

Delisted

mems

Convergance Ethanol

11 years ago

Oil/Gas/Natural Energy

Global Convergence Solutions (GCS)

153

Closed.

12 years ago

Telecommunications Networks

Evergreen Solar Inc. (fka ESLRQ)

1,532

12 years ago

Delisted

RSI positive divergence and fair SS stocks.

12 years ago

Penny Trading - Technical

COMV

Comverge, Inc.

12 years ago

Alternative Energy

EvergreenBancorp Inc (fkaEVGGQ)

13 years ago

Banking and Finance

Positive Divergence Charts

13 years ago

User's Groups

CHINA EVERGREEN ENVIRON (fka CEEC)

18 years ago

Delisted

Wide E-Convergence Technologies Americas Corp (fka

18 years ago

Delisted

Play Episode

5min

Proactive - Interviews for investors

Actinogen targets $20B Alzheimer’s market with Xanamem

Actinogen Medical Ltd Managing Director and CEO Dr Stephen Gourlay talked with Proactive at the AIM's Small and Midcap conference about the company’s lead asset, Xanamem, and its development in Alzheimer’s disease and depression. Dr Gourlay explained that Xanamem is an oral, once-a-day drug designed to modulate cortisol levels in the brain without interfering with the body’s essential stress response. “We’ve also shown some positive data, you know, phase two and depression as well, which is very exciting because that validates its mechanism,” he said. He outlined the commercial opportunity in both Alzheimer’s and depression. While depression is more prevalent, the Alzheimer's market offers larger potential revenue. He noted that current treatments either have side effects or provide only temporary cognitive improvement, whereas Xanamem could modify the disease course with a better safety profile. Dr Gourlay discussed Actinogen’s recent momentum, including positive results in a depression trial, a number of peer-reviewed publications, and the upcoming interim analysis from its Alzheimer’s trial in Australia and the US. He said, “The upside from a positive Alzheimer’s trial is completely massive… a multi-billion dollar asset.” The company is currently trading below the total investment into drug development, which Dr Gourlay described as a compelling investment case. #Actinogen #Xanamem #AlzheimersResearch #DepressionTreatment #BiotechStocks #ClinicalTrials #Neuroscience #PharmaInnovation #ASX #ProactiveInvestors

Proactive - Interviews for investors

EBR Systems nears FDA approval for CRT pacemaker

EBR Systems Inc Senior Vice President Andrew Shute talked with Proactive at the AIM maSmall and Midcap Conference about the company’s upcoming FDA decision for its leadless CRT pacemaker system. The device is designed to treat heart failure and represents the only leadless option in a market currently dominated by three players—with no direct competitor. Shute said, “We've developed the world's only leadless pacemaker to treat heart failure. And we're on track to receive FDA approval within the next two and a half weeks.”* The product already holds FDA Breakthrough Device designation, and has shown strong clinical results, including a 16.4% reduction in left ventricular end systolic volume—well above the target goal of 9.3%. Shute outlined the company's go-to-market plan, emphasizing that reimbursement is expected to begin from October 1st under the NTAP and TPT schemes, enabling an ASP of USD 45,000. The company only needs to sell around 2,200 units annually to reach USD 100 million in revenue. “We’ve got no direct competition,” he said. He also highlighted the successful completion of the FDA’s pre-approval inspection with no observations—an uncommon achievement in the medical device industry. The device, supported by data published in JAMA Cardiology, was also featured at the Heart Rhythm Society meeting in 2023. During the interim, the US commercial team will establish purchasing agreements, prepare technology committee engagements, and begin physician training for a limited market release. #EBRSystems #MedicalDevices #HeartFailureTreatment #LeadlessPacemaker #CardiacTech #FDAApproval #CRTDevice #InvestingInHealthcare #BreakthroughDevice #MedTechInnovation #JAMACardiology #HeartRhythmSociety

Proactive - Interviews for investors

Thor Explorations says Douta-West discovery adds gold ounces for upcoming PFS

Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) CEO Segun Lawson talked with Proactive's Stephen Gunnion about progress at the Douta gold project in Senegal, with a specific focus on the Douta-West licence. Lawson outlined that Thor acquired the licence a year ago and has since been advancing drilling efforts there. He confirmed the company has now made a fresh discovery, which includes oxide, free-flowing, recoverable gold material. “These are wide intersections between 12 and 20 metres wide, with very good grades between 1.3 and just over 2 grams per ton,” Lawson said. He added that the anomaly runs for approximately two kilometres and could be a significant contributor to the overall economics of the project. Lawson noted that the next step is to fully drill the strike length of the discovery zone. This will allow the company to include the newly identified ounces into its mine plan and potentially enhance the preliminary feasibility study (PFS). He also highlighted that the company is not pursuing exploration for academic purposes, but rather with a clear intent to build and deliver value to shareholders. Lawson confirmed that following the completion of the drilling campaign, Thor will provide an updated timeline for the PFS. Watch the full interview for more insights, and don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for future updates. #ThorExplorations #GoldDiscovery #MiningUpdate #SenegalMining #DrillResults #DoutaProject #GoldStocks #PFS #JuniorMining #ResourceExpansion

Proactive - Interviews for investors

Acusensus talks global expansion and growth drivers

Acusensus Ltd Managing Director talked with Proactive at AIM's Small and Midcap Conference about the company’s progress in road safety technology, its global expansion, and the upcoming launch of a new product line aimed at road worker protection. Alex Jannink, Managing Director and Co-founder of Acusensus, explained how the company pioneered enforcement cameras targeting behaviours like mobile phone use and seatbelt compliance. “We supply these automated enforcement cameras...and we receive a fixed monthly fee essentially for those services,” he said, outlining the company's outsourced business model under long-term government contracts. While 93% of revenues currently come from Australia, Jannink confirmed growth is underway internationally, with active customers in the United States and United Kingdom. Acusensus has also secured a nationwide speed enforcement contract in New Zealand, expected to contribute significantly from the next financial year. Jannink highlighted the broader social mission behind the business: “The whole goal of the company is to change behaviours and to save lives.” He pointed to strong behavioural impacts from previous deployments, including a six-fold drop in mobile phone use and a 21% reduction in road fatalities in New South Wales. A new road worker safety product line is also in development and, according to Jannink, “can be as large as the enforcement business.” #Acusensus #RoadSafety #AItechnology #TrafficEnforcement #DriverSafety #ASXStocks #GovernmentContracts #InfrastructureSafety #SmartCameras #RoadWorkerProtection #AutonomousTech #InvestSmart #PublicSafetyTech

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Board Search Results

Board Search Results

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Board Search Results

Board Search Results

Go Ad-Free